What practices support IP accountability at trial sites?

What practices support IP accountability at trial sites?

• A. Through inventory records, usage logs, reconciliations, and end-of-trial reconciliation.
• B. Through patient diaries only.
• C. By relying exclusively on sponsor-issued IP orders.
• D. By outsourcing all IP tracking to a third party.

Answer: (A)

Maintaining a clear, auditable trail of the Investigational Product at the site is essential. This involves keeping inventory records that track batch/lot numbers, quantities received, storage location, and expiration dates; recording every dispensation or administration in usage logs; performing regular reconciliations to compare what was received, what was used, and what remains; and conducting an end-of-trial reconciliation to account for all IP and confirm final disposition. Together, these practices ensure traceability, prevent loss or misreporting, and support regulatory compliance and data integrity. The other options don’t provide the full control. Patient diaries document patient experience, not IP handling. Relying only on sponsor-issued IP orders ignores on-site disposition and weakens accountability. Outsourcing all IP tracking to a third party may help, but without robust site-level records and oversight, gaps in traceability and regulatory compliance can occur.

Maintaining a clear, auditable trail of the Investigational Product at the site is essential. This involves keeping inventory records that track batch/lot numbers, quantities received, storage location, and expiration dates; recording every dispensation or administration in usage logs; performing regular reconciliations to compare what was received, what was used, and what remains; and conducting an end-of-trial reconciliation to account for all IP and confirm final disposition. Together, these practices ensure traceability, prevent loss or misreporting, and support regulatory compliance and data integrity.

The other options don’t provide the full control. Patient diaries document patient experience, not IP handling. Relying only on sponsor-issued IP orders ignores on-site disposition and weakens accountability. Outsourcing all IP tracking to a third party may help, but without robust site-level records and oversight, gaps in traceability and regulatory compliance can occur.